![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://www.dldjournalonline.com/cms/asset/4203302f-15c1-4c6a-b6e3-b0dc2193e743/gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
Comparison of MERRA-2 and ECCO-v4 ocean surface heat fluxes: Consequences of different forcing feedbacks on ocean circulation an
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn0EU1U8AIN-GX.jpg)
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
![PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany](https://i1.rgstatic.net/publication/337008399_4th_Congress_of_ECCO_-_Inflammatory_Bowel_Diseases_Impact_of_anti-TNF_treatment_on_Extra-intestinal_Manifestations_in_Patients_with_Inflammatory_Bowel_Disease_real_world_data_in_Germany/links/5dc01db392851c818028b1a3/largepreview.png)
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
![Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice | Journal of Agricultural and Food Chemistry Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice | Journal of Agricultural and Food Chemistry](https://pubs.acs.org/cms/10.1021/acs.jafc.8b03942/asset/images/large/jf-2018-03942y_0009.jpeg)
Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice | Journal of Agricultural and Food Chemistry
![PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM](https://i1.rgstatic.net/publication/330645603_OP35_Endoscopic_and_deep_remission_at_1_year_prevents_disease_progression_in_early_Crohn's_disease_long-term_data_from_CALM/links/5e85d3c7a6fdcca789e963e7/largepreview.png)
PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer. - Document - Gale Academic OneFile
![PDF) DOP037 A model for prediction of early surgery and complications in paediatric Crohn's disease: results of the prospective GROWTH CD study PDF) DOP037 A model for prediction of early surgery and complications in paediatric Crohn's disease: results of the prospective GROWTH CD study](https://i1.rgstatic.net/publication/313461063_DOP037_A_model_for_prediction_of_early_surgery_and_complications_in_paediatric_Crohn's_disease_results_of_the_prospective_GROWTH_CD_study/links/5a8d89c8a6fdcc808c0e15fe/largepreview.png)
PDF) DOP037 A model for prediction of early surgery and complications in paediatric Crohn's disease: results of the prospective GROWTH CD study
![PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience. PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.](https://i1.rgstatic.net/publication/325952662_Young_adults_living_with_inflammatory_bowel_disease_A_thematic_synthesis_of_patient_experience/links/5b2ea8854585150d23caa253/largepreview.png)
PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1I0CVwAAVbci.jpg)